Showing results (71-80 of 102) with videos related to
Sort By:
Pageof 11
The Oncologist|December 15, 2010
Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN studyJames J Vredenburgh, Timothy Cloughesy, Meghna Samant, et al.Neuro-Oncology|November 17, 2006
Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiformeMichael A Badruddoja, Kara Penne, Annick Desjardins, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13William P Peters, Gary L Rosner, James J Vredenburgh, et al.Cancer|May 26, 2004
Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphomaDavid A Rizzieri, Gregory J Sand, Dean McGaughey, et al.Neuro-Oncology|March 10, 2007
Temozolomide in children with progressive low-grade gliomaSridharan Gururangan, Michael J Fisher, Jeffrey C Allen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemiaDavid A Rizzieri, Valerie K Ibom, Joseph O Moore, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2011
Exercise behavior, functional capacity, and survival in adults with malignant recurrent gliomaEmily Ruden, David A Reardon, April D Coan, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2006
Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy aloneJames J Vredenburgh, David Coniglio, Gloria Broadwater, et al.International Journal of Radiation Oncology, Biology, Physics|June 4, 2013
Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trialAlvin R Cabrera, Kyle C Cuneo, Annick Desjardins, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Bevacizumab plus irinotecan in recurrent glioblastoma multiformeJames J Vredenburgh, Annick Desjardins, James E Herndon, et al.Pageof 11